- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 39 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 45 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 3 residues within 4Å:- Chain B: T.25, I.26, R.27
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain B: L.108, R.112
Ligand excluded by PLIPSO4.21: 3 residues within 4Å:- Chain C: D.34, T.36, Y.38
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain C: Y.35, Y.83, I.97, E.429
Ligand excluded by PLIPSO4.23: 1 residues within 4Å:- Ligands: SO4.31
Ligand excluded by PLIPSO4.24: 8 residues within 4Å:- Chain C: H.222, E.223, D.224, H.249, G.280, R.339
- Ligands: AU.19, AU.20
Ligand excluded by PLIPSO4.25: 3 residues within 4Å:- Chain C: V.558, K.559, E.560
Ligand excluded by PLIPSO4.26: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain C: Y.93, H.422, E.423, G.430
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain C: C.322
- Chain I: G.45, G.46, K.48
Ligand excluded by PLIPSO4.29: 6 residues within 4Å:- Chain B: P.66, T.69
- Chain C: I.3, Q.7, S.11, Y.12
Ligand excluded by PLIPSO4.30: 3 residues within 4Å:- Chain C: K.33, D.34, Y.35
Ligand excluded by PLIPSO4.31: 5 residues within 4Å:- Chain C: Y.60, E.64, N.65, I.114
- Ligands: SO4.23
Ligand excluded by PLIPSO4.32: 5 residues within 4Å:- Chain C: K.511
- Chain F: K.511
- Chain I: K.511
- Ligands: SO4.69, SO4.106
Ligand excluded by PLIPSO4.33: 3 residues within 4Å:- Chain C: R.513, I.514
- Ligands: EDO.37
Ligand excluded by PLIPSO4.43: 3 residues within 4Å:- Chain E: T.25, I.26, R.27
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain E: L.108, R.112
Ligand excluded by PLIPSO4.58: 3 residues within 4Å:- Chain F: D.34, T.36, Y.38
Ligand excluded by PLIPSO4.59: 4 residues within 4Å:- Chain F: Y.35, Y.83, I.97, E.429
Ligand excluded by PLIPSO4.60: 1 residues within 4Å:- Ligands: SO4.68
Ligand excluded by PLIPSO4.61: 8 residues within 4Å:- Chain F: H.222, E.223, D.224, H.249, G.280, R.339
- Ligands: AU.56, AU.57
Ligand excluded by PLIPSO4.62: 3 residues within 4Å:- Chain F: V.558, K.559, E.560
Ligand excluded by PLIPSO4.63: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPSO4.64: 4 residues within 4Å:- Chain F: Y.93, H.422, E.423, G.430
Ligand excluded by PLIPSO4.65: 4 residues within 4Å:- Chain C: G.45, G.46, K.48
- Chain F: C.322
Ligand excluded by PLIPSO4.66: 6 residues within 4Å:- Chain E: P.66, T.69
- Chain F: I.3, Q.7, S.11, Y.12
Ligand excluded by PLIPSO4.67: 3 residues within 4Å:- Chain F: K.33, D.34, Y.35
Ligand excluded by PLIPSO4.68: 5 residues within 4Å:- Chain F: Y.60, E.64, N.65, I.114
- Ligands: SO4.60
Ligand excluded by PLIPSO4.69: 5 residues within 4Å:- Chain C: K.511
- Chain F: K.511
- Chain I: K.511
- Ligands: SO4.32, SO4.106
Ligand excluded by PLIPSO4.70: 3 residues within 4Å:- Chain F: R.513, I.514
- Ligands: EDO.74
Ligand excluded by PLIPSO4.80: 3 residues within 4Å:- Chain H: T.25, I.26, R.27
Ligand excluded by PLIPSO4.81: 2 residues within 4Å:- Chain H: L.108, R.112
Ligand excluded by PLIPSO4.95: 3 residues within 4Å:- Chain I: D.34, T.36, Y.38
Ligand excluded by PLIPSO4.96: 4 residues within 4Å:- Chain I: Y.35, Y.83, I.97, E.429
Ligand excluded by PLIPSO4.97: 1 residues within 4Å:- Ligands: SO4.105
Ligand excluded by PLIPSO4.98: 8 residues within 4Å:- Chain I: H.222, E.223, D.224, H.249, G.280, R.339
- Ligands: AU.93, AU.94
Ligand excluded by PLIPSO4.99: 3 residues within 4Å:- Chain I: V.558, K.559, E.560
Ligand excluded by PLIPSO4.100: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPSO4.101: 4 residues within 4Å:- Chain I: Y.93, H.422, E.423, G.430
Ligand excluded by PLIPSO4.102: 4 residues within 4Å:- Chain F: G.45, G.46, K.48
- Chain I: C.322
Ligand excluded by PLIPSO4.103: 6 residues within 4Å:- Chain H: P.66, T.69
- Chain I: I.3, Q.7, S.11, Y.12
Ligand excluded by PLIPSO4.104: 3 residues within 4Å:- Chain I: K.33, D.34, Y.35
Ligand excluded by PLIPSO4.105: 5 residues within 4Å:- Chain I: Y.60, E.64, N.65, I.114
- Ligands: SO4.97
Ligand excluded by PLIPSO4.106: 5 residues within 4Å:- Chain C: K.511
- Chain F: K.511
- Chain I: K.511
- Ligands: SO4.32, SO4.69
Ligand excluded by PLIPSO4.107: 3 residues within 4Å:- Chain I: R.513, I.514
- Ligands: EDO.111
Ligand excluded by PLIP- 6 x NI: NICKEL (II) ION(Non-covalent)
NI.8: 7 residues within 4Å:- Chain C: K.220, H.222, H.249, H.275, G.280
- Ligands: NI.9, O.12
4 PLIP interactions:2 interactions with chain C, 1 Ligand-Water interactions, 1 Ligand-Ligand interactions- Metal complexes: C:H.249, C:H.275, H2O.7, O.12
NI.9: 6 residues within 4Å:- Chain C: H.137, H.139, K.220, D.363
- Ligands: NI.8, O.12
5 PLIP interactions:3 interactions with chain C, 1 Ligand-Water interactions, 1 Ligand-Ligand interactions- Metal complexes: C:H.137, C:H.139, C:D.363, H2O.7, O.12
NI.45: 7 residues within 4Å:- Chain F: K.220, H.222, H.249, H.275, G.280
- Ligands: NI.46, O.49
4 PLIP interactions:2 interactions with chain F, 1 Ligand-Water interactions, 1 Ligand-Ligand interactions- Metal complexes: F:H.249, F:H.275, H2O.28, O.49
NI.46: 6 residues within 4Å:- Chain F: H.137, H.139, K.220, D.363
- Ligands: NI.45, O.49
5 PLIP interactions:3 interactions with chain F, 1 Ligand-Water interactions, 1 Ligand-Ligand interactions- Metal complexes: F:H.137, F:H.139, F:D.363, H2O.28, O.49
NI.82: 7 residues within 4Å:- Chain I: K.220, H.222, H.249, H.275, G.280
- Ligands: NI.83, O.86
4 PLIP interactions:2 interactions with chain I, 1 Ligand-Water interactions, 1 Ligand-Ligand interactions- Metal complexes: I:H.249, I:H.275, H2O.49, O.86
NI.83: 6 residues within 4Å:- Chain I: H.137, H.139, K.220, D.363
- Ligands: NI.82, O.86
5 PLIP interactions:3 interactions with chain I, 1 Ligand-Water interactions, 1 Ligand-Ligand interactions- Metal complexes: I:H.137, I:H.139, I:D.363, H2O.49, O.86
- 3 x O: OXYGEN ATOM(Non-covalent)
O.12: 8 residues within 4Å:- Chain C: H.137, K.220, H.249, H.275, G.280, D.363
- Ligands: NI.8, NI.9
No protein-ligand interaction detected (PLIP)O.49: 8 residues within 4Å:- Chain F: H.137, K.220, H.249, H.275, G.280, D.363
- Ligands: NI.45, NI.46
No protein-ligand interaction detected (PLIP)O.86: 8 residues within 4Å:- Chain I: H.137, K.220, H.249, H.275, G.280, D.363
- Ligands: NI.82, NI.83
No protein-ligand interaction detected (PLIP)- 3 x AUF: triethylphosphanuidylgold(1+)(Non-covalent)
AUF.15: 4 residues within 4Å:- Chain C: Q.387, T.554, C.555, E.556
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:C.555
AUF.52: 4 residues within 4Å:- Chain F: Q.387, T.554, C.555, E.556
1 PLIP interactions:1 interactions with chain F- Metal complexes: F:C.555
AUF.89: 4 residues within 4Å:- Chain I: Q.387, T.554, C.555, E.556
1 PLIP interactions:1 interactions with chain I- Metal complexes: I:C.555
- 15 x AU: GOLD ION(Non-covalent)(Non-functional Binders)
AU.16: 1 residues within 4Å:- Chain C: M.367
No protein-ligand interaction detected (PLIP)AU.17: 1 residues within 4Å:- Ligands: AU.18
No protein-ligand interaction detected (PLIP)AU.18: 1 residues within 4Å:- Ligands: AU.17
No protein-ligand interaction detected (PLIP)AU.19: 5 residues within 4Å:- Chain C: L.319, C.322, R.339
- Ligands: AU.20, SO4.24
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:C.322
AU.20: 4 residues within 4Å:- Chain C: V.321, C.322
- Ligands: AU.19, SO4.24
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:C.322
AU.53: 1 residues within 4Å:- Chain F: M.367
No protein-ligand interaction detected (PLIP)AU.54: 1 residues within 4Å:- Ligands: AU.55
No protein-ligand interaction detected (PLIP)AU.55: 1 residues within 4Å:- Ligands: AU.54
No protein-ligand interaction detected (PLIP)AU.56: 5 residues within 4Å:- Chain F: L.319, C.322, R.339
- Ligands: AU.57, SO4.61
1 PLIP interactions:1 interactions with chain F- Metal complexes: F:C.322
AU.57: 4 residues within 4Å:- Chain F: V.321, C.322
- Ligands: AU.56, SO4.61
1 PLIP interactions:1 interactions with chain F- Metal complexes: F:C.322
AU.90: 1 residues within 4Å:- Chain I: M.367
No protein-ligand interaction detected (PLIP)AU.91: 1 residues within 4Å:- Ligands: AU.92
No protein-ligand interaction detected (PLIP)AU.92: 1 residues within 4Å:- Ligands: AU.91
No protein-ligand interaction detected (PLIP)AU.93: 5 residues within 4Å:- Chain I: L.319, C.322, R.339
- Ligands: AU.94, SO4.98
1 PLIP interactions:1 interactions with chain I- Metal complexes: I:C.322
AU.94: 4 residues within 4Å:- Chain I: V.321, C.322
- Ligands: AU.93, SO4.98
1 PLIP interactions:1 interactions with chain I- Metal complexes: I:C.322
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mazzei, L. et al., Medicinal Au(I) compounds targeting urease as prospective antimicrobial agents: unveiling the structural basis for enzyme inhibition. Dalton Trans (2021)
- Release Date
- 2022-06-01
- Peptides
- Urease subunit gamma: ADG
Urease subunit beta: BEH
Urease subunit alpha: CFI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAD
AAAG
AAAB
BBBE
BBBH
BBBC
CCCF
CCCI
CCC
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 39 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 45 x SO4: SULFATE ION(Non-functional Binders)
- 6 x NI: NICKEL (II) ION(Non-covalent)
- 3 x O: OXYGEN ATOM(Non-covalent)
- 3 x AUF: triethylphosphanuidylgold(1+)(Non-covalent)
- 15 x AU: GOLD ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mazzei, L. et al., Medicinal Au(I) compounds targeting urease as prospective antimicrobial agents: unveiling the structural basis for enzyme inhibition. Dalton Trans (2021)
- Release Date
- 2022-06-01
- Peptides
- Urease subunit gamma: ADG
Urease subunit beta: BEH
Urease subunit alpha: CFI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAD
AAAG
AAAB
BBBE
BBBH
BBBC
CCCF
CCCI
CCC